Novartis at BioTechX Europe 2026
Oct 6–8, 2026 Basel, Switzerland ~3k attendees Website
Novartis takes part in 26 sessions at BioTechX Europe 2026 in Basel, its home city. Its program covers AI across drug research, from finding promising early molecules to planning clinical trials, plus the well-organised data AI depends on. Specific topics include a virtual model of trial operations used to plan studies, and opening up Germany's health data for research beyond clinical trials.
| Organization | BioTechX Europe 2026 Attendance |
|---|---|
Novartis Basel, Switzerland | |
Global pharmaceutical company developing innovative medicines. | Chair Tue Oct 6 08:55 Keynote Tue Oct 6 09:00 How AI is changing for drug discovery at Novartis AI & large language models Keynote Tue Oct 6 09:40 The use of agentic AI in R&D AI & large language models Chair Tue Oct 6 11:40 Chair Tue Oct 6 11:40 Talk Tue Oct 6 11:45 Talk Tue Oct 6 12:45 Talk Tue Oct 6 12:45 Chair Tue Oct 6 15:25 Talk Tue Oct 6 15:50 Panel Tue Oct 6 16:30 Panel Tue Oct 6 17:25 Panel Tue Oct 6 17:25 Panel Tue Oct 6 17:25 Talk Wed Oct 7 16:10 Panel Wed Oct 7 16:30 Panel Wed Oct 7 16:30 Panel Wed Oct 7 17:25 Chair Thu Oct 8 11:05 Talk Thu Oct 8 11:05 Talk Thu Oct 8 11:50 Talk Thu Oct 8 12:10 Keynote Thu Oct 8 13:20 |
Instantly find 20 buyers from Novartis
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Terrapinn or BioTechX. Submit a correction